StopDown
4baseCare logo
Funding · 27 January 20264baseCare₹90 crorePrecision oncology company4basecare.com ↗

4baseCare raises ₹90 crore in Series B

By · Editor ·

series-bFounded 2018
  • 4baseCare is a precision oncology company that integrates genomic testing with clinical data
  • It raised ₹90 crore in a Series B round co-led by Ashish Kacholia and Lashit Sanghvi
  • The funds will expand its genomics lab network and develop AI-based clinical decision tools

What happened

  • 4baseCare announced the first close of its Series B funding round.
  • The company raised ₹90 crore (approximately $9.8 million).
  • The round was co-led by Ashish Kacholia and Lashit Sanghvi.
  • Existing investor Yali Capital also participated in the round.
  • The company plans to use the funds to expand its hospital-linked genomics lab network across India, the Middle East, Southeast Asia, Latin America, and Central Asia.
  • It will also accelerate development of AI-based clinical decision support solutions, including OncoTwin Insights.
  • OncoTwin Insights helps oncologists derive treatment insights from clinico-genomic and outcomes-linked datasets.
  • The company's OncoTwin was selected for the MSK iHub programme of Memorial Sloan Kettering Cancer Centre in New York.

Why it matters

  • The healthtech market is projected to grow at 39% CAGR from 2025 and exceed $37 billion by 2030.
  • About $700 million was raised by healthtech startups in 2025.
  • This round comes after a gap of two years since the Series A in 2024.
  • The company also received a grant from the Karnataka government in 2024.

The business

  • 4baseCare is a precision oncology company that builds population-relevant clinico-genomic intelligence.
  • It integrates genomic testing with real-world clinical and outcomes data to provide actionable insights.
  • The company works with hospitals to offer genomics-led cancer diagnostics in clinical settings.
  • Its product OncoTwin Insights helps oncologists derive treatment insights from clinico-genomic and outcomes-linked datasets.
  • The company was selected for the MSK iHub programme of Memorial Sloan Kettering Cancer Centre.

The founders

Hitesh Goswami

CEO
  • Hitesh Goswami founded 4baseCare.
  • He serves as the CEO of the company.

Who put in money

In numbers

₹90 croreSeries B amount · 2026
$9.8 millionSeries B amount in USD · 2026
₹50 croreSeries A amount · 2024
₹8.3 croreInfosys investment in Series A · 2024

What happens next

  • Expand hospital-linked genomics lab network across India, Middle East, Southeast Asia, Latin America, and Central Asia.
  • Accelerate development and deployment of AI-based clinical decision support solutions, including OncoTwin Insights.

Earlier rounds

  • 2024 · Series A · ₹50 crore · led by Yali Capital

Up against

Everhope OncologyMOC Cancer Care & Research CentreErlySignOnCareOneCell Diagnostics

Words to know

precision oncology
A medical approach that uses genetic information about a patient's cancer to tailor treatment.
genomic testing
Laboratory tests that look at a person's DNA to find changes that may cause or increase the risk of disease.
clinico-genomic
Combining clinical data (like symptoms and test results) with genomic data (DNA information).
Series B
A later-stage funding round for startups that have already proven their business model and need capital to scale.

The numbers around it

4baseCare has 2 funding rounds in StopDown's archive, Rs 128 Cr raised in all.

#The numbers around it
WhenRoundAmountLed by
11 June 2026Series BRs 128 CrgrowX Ventures

Healthcare & Life Sciences in January 2026: 12 rounds with a disclosed amount, $99.0 million in all; the biggest was Sukino ($31M). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

Everything on 4baseCare → · All startup news on 27 January 2026 →

Is this 4baseCare? Get your “Featured on StopDown” badge →